Cvs Health (CVS) Other financing activities (2009 - 2026)

Cvs Health (CVS) has reported Other financing activities for 18 consecutive years, with $114.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other financing activities rose 142.55% year-over-year to $114.0 million; the trailing twelve-month figure through Jun 2026 stood at $420.0 million (up 29.63% YoY), and the FY2025 full-year result was $394.0 million, up 9.14% from the prior year.
• Other financing activities advanced to $114.0 million in Q2 2026 per CVS's latest filing, from $103.0 million in the prior quarter.
• Across five years, Other financing activities topped out at $363.0 million in Q3 2023 and bottomed at -$128.0 million in Q1 2023.
• Historically, Other financing activities has averaged $100.0 million across 5 years, with a median of $94.5 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Other financing activities plunged 143.1% in 2023, then jumped 352.63% in 2025.
• Over 5 years, Other financing activities stood at $41.0 million in 2022, then retreated by 14.63% to $35.0 million in 2023, then slumped by 45.71% to $19.0 million in 2024, then surged by 352.63% to $86.0 million in 2025, then jumped by 32.56% to $114.0 million in 2026.
• According to Business Quant data, Other financing activities over the past three periods registered $114.0 million, $103.0 million, and $86.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.